lobbying_activities: 3200831

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3200831	34a06cb7-ee48-4a6b-9f84-7a59a2e86f40	Q2	TRUSYNERGY	401107715	BURRELL INTERNATIONAL GROUP LLC (ON BEHALF OF SHIONOGI INC.)	2024	second_quarter	PHA	Funding for the SNS, BARDA, and IBMSC; promoting safer and more effective treatments in the stockpile; promoting onshoring and domestic manufacturing of medicines and their components; prioritizing investments in more effective treatments to combat AMR; PASTEUR Act; reauthorization of the Pandemic and All Hazards Preparedness Act; funding and incentives for MCM development; AMR issues; development of infectious disease and AMR treatments; FY 25 LHHS appropriations; MCM PRV; SUPER BUGS Act	HOUSE OF REPRESENTATIVES,SENATE	10000		0	0	2024-07-18T16:44:46-04:00